Targeting NUPR1 for Cancer Treatment: A Risky Endeavor-Reference-Cited by-同舟云学术

Targeting NUPR1 for Cancer Treatment: A Risky Endeavor

Published:2020-11-02 Issue:10 Volume:20 Page:768-778
ISSN:1568-0096
Container-title:Current Cancer Drug Targets
language:en
Short-container-title:CCDT

Author:

Mansour Salma M.A.¹,Ali Sahar A.²,Nofal Shaira³,Soror Sameh H.²^ORCID

Affiliation:

1. Egyptian Patent Office, Academy of Scientific Research and Technology (ASRT), 101 Kaser Al-Ainy Street, Cairo, Egypt

2. Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Ain Helwan, Helwan Cairo 11795, Egypt

3. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Ain Helwan, Helwan Cairo 11795, Egypt

Abstract

NUPR1 is a transcription factor that has attracted great attention because of its various roles in cancer. Several studies were carried out to determine its molecular targets and mechanism of action to develop novel therapies against cancer. Here, we shed light on the role of NUPR1 in different types of cancer. NUPR1 regulates a complex network of pathways that may be affected by its silencing, which can cause varying effects. Its role in some types of cancer has been reported but remains incompletely understood, whereas its roles in other types of cancers have not been reported yet. Therefore, targeting NUPR1 for cancer treatment remains challenging and risky.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Drug Discovery,Pharmacology,Oncology

Reference82 articles.

1. Emma M.R.; Iovanna J.L.; Bachvarov D.; Puleio R.; Loria G.R.; Augello G.; Candido S.; Libra M.; Gulino A.; Cancila V.; McCubrey J.A.; Montalto G.; Cervello M.; NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance. Cell Death Dis 2016,7(6)

2. Goruppi S.; Kyriakis J.M.; The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4. J Biol Chem 2004,279(20),20950-20958

3. Encinar J.A.; Mallo G.V.; Mizyrycki C.; Giono L.; González-Ros J.M.; Rico M.; Cánepa E.; Moreno S.; Neira J.L.; Iovanna J.L.; Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 2001,276(4),2742-2751

4. Urrutia R.; Velez G.; Lin M.; Lomberk G.; Neira J.L.; Iovanna J.; Evidence supporting the existence of a NUPR1-like family of helix-loop-helix chromatin proteins related to, yet distinct from, AT hook-containing HMG proteins. J Mol Model 2014,20(8),2357

5. Mallo G.V.; Fiedler F.; Calvo E.L.; Ortiz E.M.; Vasseur S.; Keim V.; Morisset J.; Iovanna J.L.; Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 1997,272(51),32360-32369

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NUPR1 imparts oncogenic potential in bladder cancer;Cancer Medicine;2022-12-05

2. Role of NRP1 in Bladder Cancer Pathogenesis and Progression;Frontiers in Oncology;2021-06-23